- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Priority Health Leadership Recognized Yet Again
It has been an award-filled year for Priority Health, based in Grand Rapids, Michigan, and Megan Schmidt, senior vice president of employer solutions, has added to the accolades with her inclusion in the inaugural leadership class of BenefitsPRO Luminaries.
Grand Rapids, Michigan — Seven leaders from the benefits and health care industries have been recognized for their transformative efforts in the area of health benefits by being included in the inaugural leadership class of BenefitsPRO Luminaries. Among them is Priority Health's Megan Schmidt, senior vice president of employer solutions, the only MIchigander so recognized.
“I am proud to lead a team of dedicated professionals who work tirelessly to provide employers with the best resources and tools to keep their workforce healthy and productive," Schmidt said. "This recognition reflects their solid, and very important, work.”
With the recognition, Schmidt is included in the Novemger issue of BenefitsPRO Magazine. She has 20-plus years of experience in the health benefits industry and leads a team whose goal is to simplified, affordable, and exceptional personzalized health care.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More
